- Sweden
- /
- Life Sciences
- /
- OM:PRO
Promimic Reports First Quarter 2025 Earnings
Promimic (STO:PRO) First Quarter 2025 Results
Key Financial Results
- Revenue: kr11.0m (up 17% from 1Q 2024).
- Net loss: kr4.48m (loss widened by 28% from 1Q 2024).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Promimic shares are down 23% from a week ago.
Risk Analysis
We don't want to rain on the parade too much, but we did also find 3 warning signs for Promimic (1 shouldn't be ignored!) that you need to be mindful of.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About OM:PRO
Promimic
Manufactures, markets, and sells biomaterials for improved osseointegration for orthopedic and dental implants markets.
Flawless balance sheet with very low risk.
Market Insights
Weekly Picks

An Undervalued 3.3Moz Gold Project in Canada

GameStop will ace the financial crisis wave with its strategic Bitcoin investment and cash reserves
The First Real Lidar Winner

The Most Wonderful Monopoly in the Most Dangerous Neighbourhood on Earth
Recently Updated Narratives

5E Advanced Materials (FEAM): A Binary Critical Minerals Play with a $6.65 Fair Value Target
Recursion Pharmaceuticals! WTH is going on?

Visa and the Case for Patience in Premium Businesses
Popular Narratives

Everyone's Terrified Microsoft Will Keep Spending. I'm Terrified They'll Stop.

Analyst Commentary Highlights Microsoft AI Momentum and Upward Valuation Amid Growth and Competitive Risks
